Dr Gerard D'Souza was awarded by Targeting Mitochondria 2012 Scientific Committee
Dr Gerard D'Souza from Massachusetts College of Pharmacy and Health Sciences, USA, was awarded during Targeting Mitochondria 2012 for his scientific contribution for his work about Functional Expression of Green Fluorescent Protein in Mitochondria of Rat Cells Following Liposome-Mediated Delivery of a Linear DNA Construct.
Scientific Committee of Targeting Mitochondria awarded Dr Shanta Dhar for her work
During Targeting Mitochondria 2012, the Scientific Committee awarded Dr Shanta Dhar for her Scientific Contribution.
Pr Shanta Dhar will present recent researches about Delivering drugs via nanoparticles to target mitochondria: Positive results shown for cancer, Alzheimer’s and obesity drugs during Targeting Mitochondria 2012
Researchers at the University of Georgia have refined the nanoparticle drug delivery process further by using nanoparticles to deliver drugs to a specific organelle within cells.
By targeting mitochondria, “the powerhouse of cells,” the researchers increased the effectiveness of mitochondria-acting therapeutics used to treat cancer, Alzheimer’s disease and obesity in studies conducted with cultured cells.
Targeting Mitochondria Networking 2012 is organized around Cocktail and Snacks with international companies and academics
Targeting Mitochondria attendees, academics and industrials, are invited to a warm-up networking session over a cocktail and snacks.
Cationic derivative of plastoquinone (visomitin), the first mitochondria-targeted medicine available in drugstores
Pr Vladimir Skulachev, from Lomonosov Moscow State University, Moscow, Russia will present his recent researches about a concept was put forward considering mitochondrial reactive oxygen species (mROS) as key intermediates of programmed aging of organism during the 3rd World Congress on Targeting Mitochondria, which will be held in Berlin on November 8-9, 2012.
Two hot topics for Targeting Mitochondria 2012: Mito-Devices & Mito-Engineering
The Scientific Committee has selected two hot topics for this year’s meeting.
The first topic involves Mito-Devices, which are novel tools for probing mitochondrial function under physiological and pathological conditions.
The abstracts book of Targeting Mitochondria 2010 & 2011 are available with special discount
The abstracts book of Targeting Mitochondria 2010 is available freely.
Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of MTDNA mutation
There is emerging evidence that people with successfully treated HIV infection age prematurely, leading to progressive multi-organ disease, but the reasons for this are not known.
The Strategic Role of Chemistry to Target Mitochondria will be discussed by Dr Richard Hartley
Mitochondria are central to the healthy functioning of the cell, both in terms of metabolism and signaling, but also play a key role in the process of apoptosis.
Dr Meagan McManus, from Center for Mitochondrial and Epigenomic Medicine, will introduce Targeting Mitochondria 2012 on behalf of Pr Douglas Wallace
Pr Douglas Wallace will receive the Gruber Genetics Prize for Groundbreaking Contributions to Mitochondrial Genetics. The award ceremony will be held on November 9, and it is why he invited Dr Meagan McManus to introduce Targeting Mitochondria 2012,
ISANH & Targeting Mitochondria Committees congratulate Pr Douglas C. Wallace, for his Gruber Genetics Prize for Groundbreaking Contributions to Mitochondrial Genetics
Pr Douglas C. Wallace, a pioneering genetics researcher who founded the field of mitochondrial genetics in humans, will receive the $500,000 Gruber Genetics Prize 2012 for Groundbreaking Contributions to Mitochondrial Genetics.
The Mitochondria Engineering Concept: Challenges & Limits
During Targeting Mitochondria 2012, the scientific committee selected two hot topics for 2012 edition: Mito-Devices & Mito-Engineering.
Correcting human mitochondrial mutations with targeted RNA import: A hot topic presented by M. Teitell during Targeting Mitochondria 2012
Mutations in the human mitochondrial genome are implicated in neuromuscular diseases, metabolic defects, and aging.
More Articles...
- Dr Yuma Yamada, from Faculty of Pharmaceutical Sciences, Hokkaido, Japan will give a talk about Development of nanotechnology to deliver bioactive molecules to mitochondria
- The Scientific Committee of Targeting Mitochondria 2012 is honoured to welcoming Pr Douglas Wallace, from Center for Mitochondrial and Epigenomic Medicine, Philadelphia, USA during Targeting Mitochondria 2012
- Berlin will host the most important meeting on mitochondria which will target a challenging topic: Mitochondria Engineering
- Targeting Mitochondria 2012 will be organized for the third year in Berlin in November 2012
